Mr. Rob Gietl reports

MYM SIGNS MOU WITH COLOMBIAN MEDICAL CANNABIS COMPANY NEWCANNA

MYM Nutraceuticals Inc. has signed a memorandum of understanding with Newcanna SAS, a leading Colombian medical cannabis company.

MYM and Newcanna are proposing a joint venture or partnership agreement in which they would form a new, jointly owned company in Colombia. This partnership would focus on the large-scale commercial cultivation and transformation of cannabis and hemp for medical, scientific and industrial purposes and export to worldwide markets.

Newcanna has agreements in place with multiple indigenous communities in Colombia totalling over 400 families (approximately 1,400 people) that control 7,400 acres of cultivation property. In 2018, the indigenous growers have the capacity to be producing approximately 217,500 kilograms of high-grade cannabis for processing and export around the world. With planned production expansion with the indigenous growers, Newcanna's production is expected to be over one million kilograms of cannabis in a year or two. The high mountains of Colombia provide a perfect climate to cultivate cannabis and allow production costs to be a fraction of what it costs to produce in Canada.

MYM and Newcanna are also proposing that, along with the cultivation and transformation of raw materials into medicinal oils, tinctures and a variety of products, they also construct a research and development laboratory for the design and creation of new products, in-house analysis and testing, and the refinement of new and unique delivery systems.

In the last year, Newcanna has consolidated vast properties of land that are ideal for the cultivation of cannabis and hemp throughout different regions of Colombia. Newcanna has formed valuable alliances with multiple indigenous communities within Colombia and has a large work force of eager participants for all planned organic cultivation projects.

"This is a tremendous opportunity and another big step towards MYM's stated goal of becoming a global cannabis player," said Rob Gietl, chief executive officer of MYM. "Newcanna has the infrastructure in place to dominate the Colombian cannabis markets both domestically and for exportation to the rest of the world. Newcanna's commitment to working with the indigenous population of Colombia satisfies MYM's position to work with local communities and provides economic benefits to local inhabitants."

Under the memorandum of understanding, Newcanna will supply the land, the work force and all the applicable licences needed for the new company to move forward and operate legally under the newly established laws in Colombia. The new company will have the opportunity to become part of the Newcanna hub, a group of unique companies dedicated to the research, education and sustainability for the commercial future of cannabis in Colombia. The members and alliances of the hub come from a wide variety of backgrounds surrounding the legalities of cultivation, production, transformation, and the continuing studies of cannabis, cannabinoids, and the endocannabinoid system in humans and animals.

MYM has retained Colombian law firm Dentons Cardenas & Cardenas Abogados Ltda. to represent MYM's interests in Colombia moving ahead with the Newcanna memorandum of understanding. There can be no assurance that the transaction contemplated by the memorandum of understanding will be successfully completed.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals is an innovative company focused on acquiring Health Canada licences to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that, when completed, will have over 1.5 million square feet of production space. MYM is also a partner in a 1.2-million-square-foot production project (the Northern Rivers project) in New South Wales, Australia. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceutical and CBD (cannabidiol) sectors.

We seek Safe Harbor.